Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report)’s stock price dropped 3.9% during trading on Wednesday . The stock traded as low as $0.48 and last traded at $0.49. Approximately 147,745 shares were traded during trading, a decline of 83% from the average daily volume of 891,624 shares. The stock had previously closed at $0.51.
Azitra Price Performance
The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.77 and a current ratio of 0.77.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last issued its earnings results on Monday, August 12th. The company reported ($2.74) EPS for the quarter, missing analysts’ consensus estimates of ($2.59) by ($0.15). The business had revenue of $0.01 million for the quarter. As a group, sell-side analysts forecast that Azitra, Inc. will post -3.06 earnings per share for the current year.
Azitra Company Profile
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Read More
- Five stocks we like better than Azitra
- Stock Sentiment Analysis: How it Works
- Rocket Lab is the Right Stock for the Right Time
- How to Effectively Use the MarketBeat Ratings Screener
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What is a buyback in stocks? A comprehensive guide for investors
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
